In addition, using a novel Rycal drug (S107), which crosses the blood-brain barrier and fixes the leak in RyR2 channels (54, 58, 70), we further determined whether inhibiting RyR2-mediated ER Ca2+ leak can improve cognitive function in a murine model of HD. This evidence concerns the gene RYR2 and Huntington disease.